Human Mutation · 1995 · 55 citations · 15 references
MedicineGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsMolecular PathologyBone DysplasiasConnective Tissue DiseasesConnective Tissue DisordersGenetic DisordersSkeletal DevelopmentSkeletal DysplasiasCollagen Biosynthesis DisordersCollagen-related DefectsConnective Tissue Gene MutationsDominant Negative EffectsDominant Negative MutationsFrameshift MutationsSchmid Metaphyseal ChondrodysplasiaSkeletal Dysplasia Mutations
Schmid metaphyseal chondrodysplasia (SMCD) has previously been shown to be the result of mutations in the type X collagen gene, COL10A1. A further three mutations have been identified, including two nonsense mutations (Y268X, W651X) and a frameshift mutation (1856delCC). Each of the 10 SMCD mutations identified to date is within the C-terminal noncollagenous domain of type X collagen and three of five deletions initiated around the same nucleotide. This domain is believed to be involved in the initiation of collagen trimerization. The concentration of mutations within this domain is consistent with the hypothesis that the phenotype is the result of a reduction in the level of mature type X collagen due to the mutant polypeptide's inability to participate in trimer formation, although a dominant-negative mechanism cannot be discounted, on the basis of current evidence.
15
Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene
Harry C. Dietz, Carry Cutting, Reed E. Pyeritz et al. · Nature · 1991 · 2.1K citations
A type X collagen mutation causes Schmid metaphyseal chondrodysplasia
Matthew L. Warman, Margaret H. Abbott, Suneel Apte et al. · Nature Genetics · 1993 · 267 citations